Does BOTULINUM TOXIN TYPE A Cause Maternal exposure during pregnancy? 716 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 716 reports of Maternal exposure during pregnancy have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 19.1% of all adverse event reports for BOTULINUM TOXIN TYPE A.
716
Reports of Maternal exposure during pregnancy with BOTULINUM TOXIN TYPE A
19.1%
of all BOTULINUM TOXIN TYPE A reports
585
Deaths
474
Hospitalizations
How Dangerous Is Maternal exposure during pregnancy From BOTULINUM TOXIN TYPE A?
Of the 716 reports, 585 (81.7%) resulted in death, 474 (66.2%) required hospitalization, and 460 (64.2%) were considered life-threatening.
Is Maternal exposure during pregnancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 716 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
Gastrooesophageal reflux disease (660)
What Other Drugs Cause Maternal exposure during pregnancy?
CERTOLIZUMAB PEGOL (9,013)
ADALIMUMAB (7,518)
PREDNISONE (6,587)
METHOTREXATE (6,223)
RITUXIMAB (6,093)
INFLIXIMAB (6,061)
HYDROXYCHLOROQUINE (5,809)
FOLIC ACID (5,768)
TOCILIZUMAB (5,737)
LEFLUNOMIDE (5,643)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Maternal exposure during pregnancy Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE